TrialJournal of cosmetic dermatology2025

Comparing Ready-to-Use and Powder AbobotulinumtoxinA for Glabellar Lines: A Randomized, Controlled, Triple-Blinded Clinical Trial.

Silvio Ventura da Silva Junior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.